Theodore Alan Huizenga - Net Worth and Insider Trading
Theodore Alan Huizenga Net Worth
The estimated net worth of Theodore Alan Huizenga is at least $2 Million dollars as of 2024-05-05. Theodore Alan Huizenga is the SVP, Chief Accounting Officer of Ultragenyx Pharmaceutical Inc and owns about 41,380 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $2 Million. Details can be seen in Theodore Alan Huizenga's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Theodore Alan Huizenga has not made any transactions after 2024-03-01 and currently still holds the listed stock(s).
Transaction Summary of Theodore Alan Huizenga
Theodore Alan Huizenga Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Theodore Alan Huizenga owns 1 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) .
Click here to see the complete history of Theodore Alan Huizenga’s form 4 insider trades.
Insider Ownership Summary of Theodore Alan Huizenga
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2024-03-01 | Controller and PAO |
Theodore Alan Huizenga Latest Holdings Summary
Theodore Alan Huizenga currently owns a total of 1 stock. Theodore Alan Huizenga owns 41,380 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 1, 2024, with a value of $2 Million.
Latest Holdings of Theodore Alan Huizenga
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2024-03-01 | 41,380 | 42.75 | 1,768,995 |
Holding Weightings of Theodore Alan Huizenga
Theodore Alan Huizenga Form 4 Trading Tracker
According to the SEC Form 4 filings, Theodore Alan Huizenga has made a total of 18 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 341 shares on March 1, 2024, which brought Theodore Alan Huizenga around $18,332.
Insider Trading History of Theodore Alan Huizenga
- 1
Theodore Alan Huizenga Trading Performance
Theodore Alan Huizenga Ownership Network
Theodore Alan Huizenga Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Theodore Alan Huizenga is the Controller and PAO of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , CBO & Senior Vice President Thomas Richard Kassberg , and EVP and General Counsel Karah Herdman Parschauer .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Theodore Alan Huizenga made 5 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 5,605. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 127,435 shares made by Emil D Kakkis , a net sale of 54,366 shares made by Thomas Richard Kassberg , and a net sale of 14,737 shares made by Erik Harris .
In summary, during the past 3 months, insiders sold 69,487 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 69,487 shares. During the past 18 months, 243,647 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,647 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Theodore Alan Huizenga Mailing Address
Above is the net worth, insider trading, and ownership report for Theodore Alan Huizenga. You might contact Theodore Alan Huizenga via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
